| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0072 | 0.9 |